Clinical evaluation of a new model of a transcutaneous electrical nerve stimulation device for the management of primary dysmenorrhea.
Transcutaneous electrical nerve stimulation (TENS) has been proven effective in pain relief of primary dysmenorrhea (PD). We evaluated the efficacy of a new TENS device (Freelady, Life Care, Tiberias, Israel), designed to correct disadvantages of older models used in previous studies, in 102 nulliparous women with PD, who were treated with various types of pain relief medications. Marked pain relief was reported by 58 patients (56.9%) and moderate relief by 31 (30.4%). These subjective findings were supported by the fact that the same number of patients (58 and 31) either stopped analgesic use altogether during the trial or reduced the quantity of analgesics, respectively. The device examined proved to be efficient and safe in controlling the pain and disability caused by PD.
Kaplan
B
B
Department of Obstetrics and Gynecology, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.
Rabinerson
D
D
Lurie
S
S
Peled
Y
Y
Royburt
M
M
Neri
A
A
D000293:Adolescent; D000328:Adult; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004412:Dysmenorrhea / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D059408:Pain Management; D012449:Safety; D004561:Transcutaneous Electric Nerve Stimulation / Q000295:instrumentation*; D016896:Treatment Outcome
D000700:Analgesics